Libre

U.K. FreeDM2 randomized controlled trial: At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. …

On January 5, Abbott released a new feature within their Libre continuous glucose monitoring (CGM) app. Powered by artificial intelligence (AI), the new Libre Assist can help you figure out …

Before you even take a bite of the food on your plate, Libre Assist can tell you how it might impact your glucose levels. Abbott, the creator of continuous glucose monitors, …

Behind every diagnosis lives a human story filled with resilience, struggle, and love. In this new collaboration with Abbott, The …

Abbott's Libre® Technology is the first continuous glucose monitor associated with reduced hospitalizations for cardiac complications in diabetic patients New data reveal a 78% reduction in cardiovascular disease-related hospitalizations in …

A continuous glucose monitor (CGM) is a monitoring device used by people with diabetes. They apply them directly to the skin and monitor blood sugar readings in real time. Dexcom’s …